Department of nuclear medicine, municipal key department, mainly carries out I131 radiotherapy for hyperthyroidism and well-differentiated thyroid carcinoma;153SM-EDTMP89SR for osseous metastasisimplantation I 125 for solid tumors. In the field of detection in vitro, the department develops the following detection items: series of; thyroid hormones, thyroid hormones, sexual hormone, diabetes. In terms of imaging, the department conducts all the SPECT imaging and PET tumor imaging. The work provides support for clinic and research as well.

Experts

Haizhong Zhou: Chief Physician, Associate professor, Director of Department of nuclear medicine.

Xiaoqiang Liu��Associate Chief Professor.

Mingming Yu:Attending Physician. MD